Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | APOE |
| Upstream (Parents) |
|---|
| (<<) ACTB → APOE |
| (<<) HLA-DQA2///HLA-DQA1 → APOE |
| (<<) C1QA → APOE |
| Downstream (Children) |
|---|
| APOE → SULF1 (>>) |
| APOE → SULT2A1 (>>) |
| APOE → CPM (>>) |
| APOE → APOC1 (>>) |
| APOE → RAP2B///RAP2A (>>) |
| APOE → CYBA (>>) |
| APOE → SYT1 (>>) |
| APOE → IFI27 (>>) |
| APOE → PLXNC1 (>>) |
| APOE → FCGR3B///FCGR3A (>>) |
| APOE → ATP6V0A2 (>>) |
| APOE → RPL37P21///LOC100131269 (>>) |
| APOE → ZNF614 (>>) |
| APOE → IFI30 (>>) |
| APOE → SLC43A3 (>>) |
| APOE → NIP7 (>>) |
